Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The book provides a detailed guide on managing Polycystic Ovary Syndrome and is useful for physicians.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

Heavy metals in personal care products can cause serious health issues like cancer and hair loss.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.